Praziquanamine is a synthetic pyrazinoisoquinoline derivative recognized as a key impurity related to the anthelmintic agent praziquantel, which is widely utilized for treating schistosomiasis and various… Read more
Praziquanamine is a synthetic pyrazinoisoquinoline derivative recognized as a key impurity related to the anthelmintic agent praziquantel, which is widely utilized for treating schistosomiasis and various trematode infections. This category features Praziquanamine alongside specific derivatives, including its nitroso and stable isotope labelled forms, which serve as critical reference standards for pharmaceutical analysis. Laboratories rely on these high-quality compounds for precise impurity profiling, enabling the accurate identification and quantification of degradation products within drug formulations. By incorporating these materials into analytical workflows, researchers can effectively validate method sensitivity and specificity, particularly when performing high-resolution mass spectrometry. These reference materials are essential for quality control testing, ensuring compliance with regulatory requirements throughout the drug development and manufacturing lifecycle of praziquantel-based medications.